What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: How Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors May Change Iron Management in End-Stage Renal Disease.
about
What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: How Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors May Change Iron Management in End-Stage Renal Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
What are the Considerations in ...... nt in End-Stage Renal Disease.
@en
What are the Considerations in ...... nt in End-Stage Renal Disease.
@nl
type
label
What are the Considerations in ...... nt in End-Stage Renal Disease.
@en
What are the Considerations in ...... nt in End-Stage Renal Disease.
@nl
prefLabel
What are the Considerations in ...... nt in End-Stage Renal Disease.
@en
What are the Considerations in ...... nt in End-Stage Renal Disease.
@nl
P2860
P356
P1433
P1476
What are the Considerations in ...... nt in End-Stage Renal Disease.
@en
P2093
Anatole Besarab
Lynda Szczech
P2860
P356
10.1111/SDI.12553
P577
2016-10-04T00:00:00Z